Given the well-known role of AFP in reflecting the tumor burden and biological behavior in liver cancer, we hypothesized that an early AFP response could indicate favorable tumor dynamics in response to therapy, whereas a lack of response may suggest the need for treatment adjustments. This evidence concerns the gene AFP and liver cancer.